16.85
16.85 (0.00%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Insurance - Life (US) | Mixed | Mixed |
| Insurance - Life (Global) | Mixed | Bullish | |
| Stock | aTyr Pharma, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -3.0 |
| Price Volatility | -4.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | -1.75 |
|
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis. |
|
| Sector | Financial Services |
| Industry | Insurance - Life |
| Investment Style | Small Value |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| ACCEL GROWTH FUND IV L.P. | 15.05 | 15.05 | 0 | 0 |
| BOTHA ROELOF | 17.03 | 15.05 | 260,525 | 4,949,975 |
| COLIS PETER GEORGE | - | 15.05 | -7,061,391 | -97,800,890 |
| GV 2017 GP, L.L.C. | 15.05 | 15.05 | 3,770,156 | 56,740,848 |
| KUCHARSKI BRANDT WALTER | - | 15.05 | -65,665 | -187,041 |
| LANTZ ERIN N | - | 15.05 | -227,464 | -2,448,289 |
| MULLIN MARK W. | 15.05 | - | 5,263 | 79,208 |
| SC US (TTGP), LTD. | 15.05 | 15.05 | 0 | 0 |
| SHARMA VIPUL | - | 15.05 | -412,132 | -3,010,000 |
| WANG LINGKE | - | 15.05 | -6,556,043 | -92,487,021 |
| WHEELER WILLIAM J | 15.05 | - | 260,525 | 3,920,901 |
| Aggregate Net Quantity | -10,026,226 | |||
| Aggregate Net Value ($) | -130,242,309 | |||
| Aggregate Avg. Buy ($) | 15.54 | |||
| Aggregate Avg. Sell ($) | 15.05 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| GV 2017 GP, L.L.C. | 30 Jan 2026 | Acquired (+) | 5,615,464 | 15.05 | 84,512,733 | |
| GV 2017 GP, L.L.C. | 30 Jan 2026 | Sell (-) | 1,845,308 | 15.05 | 27,771,885 | |
| WANG LINGKE | Officer | 30 Jan 2026 | Disposed (-) | 3,943,281 | 15.05 | 59,346,379 |
| WANG LINGKE | Officer | 30 Jan 2026 | Disposed (-) | 2,202,036 | 15.05 | 33,140,642 |
| LANTZ ERIN N | Officer | 30 Jan 2026 | Sell (-) | 162,677 | 15.05 | 2,448,289 |
| COLIS PETER GEORGE | Officer | 30 Jan 2026 | Disposed (-) | 6,154,683 | 15.05 | 92,627,979 |
| COLIS PETER GEORGE | Officer | 30 Jan 2026 | Disposed (-) | 343,715 | 15.05 | 5,172,911 |
| KUCHARSKI BRANDT WALTER | Officer | 30 Jan 2026 | Sell (-) | 12,428 | 15.05 | 187,041 |
| MULLIN MARK W. | Director | 30 Jan 2026 | Buy (+) | 5,263 | 15.05 | 79,208 |
| WHEELER WILLIAM J | Director | 30 Jan 2026 | Buy (+) | 260,525 | 15.05 | 3,920,901 |
| SHARMA VIPUL | Officer | 30 Jan 2026 | Sell (-) | 200,000 | 15.05 | 3,010,000 |
| BOTHA ROELOF | Director | 30 Jan 2026 | Acquired (+) | 12,000,124 | 15.05 | 180,601,866 |
| BOTHA ROELOF | Director | 30 Jan 2026 | Disposed (-) | 12,000,124 | 15.05 | 180,601,866 |
| SC US (TTGP), LTD. | 30 Jan 2026 | Acquired (+) | 12,000,124 | 15.05 | 180,601,866 | |
| SC US (TTGP), LTD. | 30 Jan 2026 | Disposed (-) | 12,000,124 | 15.05 | 180,601,866 | |
| ACCEL GROWTH FUND IV L.P. | 30 Jan 2026 | Acquired (+) | 6,780,975 | 15.05 | 102,053,674 | |
| ACCEL GROWTH FUND IV L.P. | 30 Jan 2026 | Disposed (-) | 6,780,975 | 15.05 | 102,053,674 | |
| ACCEL GROWTH FUND IV L.P. | 30 Jan 2026 | Acquired (+) | 362,911 | 15.05 | 5,461,811 | |
| ACCEL GROWTH FUND IV L.P. | 30 Jan 2026 | Disposed (-) | 362,911 | 15.05 | 5,461,811 | |
| WANG LINGKE | Officer | 29 Jan 2026 | Disposed (-) | 410,726 | 0.00 | 0 |
| LANTZ ERIN N | Officer | 29 Jan 2026 | Disposed (-) | 64,787 | 0.00 | 0 |
| COLIS PETER GEORGE | Officer | 29 Jan 2026 | Disposed (-) | 562,993 | 0.00 | 0 |
| KUCHARSKI BRANDT WALTER | Officer | 29 Jan 2026 | Disposed (-) | 53,237 | 0.00 | 0 |
| SHARMA VIPUL | Officer | 29 Jan 2026 | Disposed (-) | 212,132 | 0.00 | 0 |
| BOTHA ROELOF | Director | 29 Jan 2026 | Buy (+) | 260,525 | 19.00 | 4,949,975 |
| LANTZ ERIN N | Officer | 28 Jan 2026 | Option execute | 85,244 | - | - |
| Show more | ||||||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |